Corporate Governance: financially beneficial to R&D intensive companies?
The Bienentanz Buzz Letter reports on the results of some new studies
Evidence is mounting that Corporate Governance brings about tangible financial benefits for companies. The current edition of the Bienentanz Buzz Letter reports on two comprehensive recent studies that have analysed the effects of a broad range of governance devices and that have determined and quantified their impacts on the costs of both debt and equity capital. A further empirical study has identified some measures that specifically biotech companies tend to adopt. Due to their focus on R&D they have different governance issues to address than other companies.
The Bienentanz Buzz Letter is a life science management newsletter that focuses on subjects that receive little attention elsewhere and has a built a reputation for its clear, crisp synopses on a wide variety of issues. The Bienentanz Buzz Letter can be subscribed free of charge.
Other news from the department business & finance
